Deciphera Pharmaceuticals Inc (NASDAQ:DCPH)
| 15.45 Delayed Data As of 3:59pm ET |  +0.44 / +2.93%Today’s Change | 8.83 Today|||52-Week Range 22.76 | -5.74% Year-to-Date |
Latest DCPH News | Press Releases
| Why Is Apellis Pharmaceuticals, Inc. (APLS) Down 7% Since Last Earnings Report? Mar 23 / Zacks.com - Paid Partner Content | Why Deciphera Pharmaceuticals Stock Jumped This Week Mar 16 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 15.01 |
| Today’s open | 15.02 |
| Day’s range | 15.02 - 15.61 |
| Volume | 10,279 |
| Average volume (3 months) | 747,890 |
| Market cap | $1.3B |
Data as of 3:59pm ET, 03/29/2023
Growth & Valuation
| Earnings growth (last year) | +54.11% |
| Earnings growth (this year) | +4.33% |
| Earnings growth (next 5 years) | +21.00% |
| Revenue growth (last year) | +39.41% |
| P/E ratio | NM |
| Price/Sales | 9.23 |
| Price/Book | 3.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CDMOAvid Bioservices Inc | +0.25 | +1.37% |
| GERNGeron Corp | +0.06 | +2.76% |
| PTGXProtagonist Therapeu... | +1.34 | +6.37% |
| REPLReplimune Group Inc | +0.04 | +0.21% |
Data as of 4:00pm ET, 03/29/2023
Financials
| Next reporting date | May 9, 2023 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $134.0M |
| Annual profit (last year) | -$178.9M |
| Net profit margin | -133.49% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
